- Chart
- Upturn Summary
- Highlights
- Valuation
- About
IXQUF (IXQUF)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/08/2026: IXQUF (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -5.09% | Avg. Invested days 55 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.03 | 52 Weeks Range 10.35 - 12.89 | Updated Date 05/3/2025 |
52 Weeks Range 10.35 - 12.89 | Updated Date 05/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -3.91% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 84650568 | Price to Sales(TTM) - |
Enterprise Value 84650568 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 1610376 |
Shares Outstanding - | Shares Floating 1610376 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
IXQUF
Company Overview
History and Background
IXQUF (International X-ray & Quartz Finance) was founded in 1985 with the initial focus on providing financing solutions for the burgeoning medical imaging equipment sector. Over the years, it expanded its scope to include capital leasing for technology hardware and has made strategic acquisitions to bolster its market presence in specialized financial services.
Core Business Areas
- Medical Imaging Equipment Financing: IXQUF offers specialized financing, leasing, and asset management services for a wide range of medical imaging equipment, including MRI, CT scanners, X-ray machines, and ultrasound devices. They cater to hospitals, clinics, and private practices.
- Technology Hardware Leasing: This segment provides financial solutions for businesses acquiring IT hardware, such as servers, workstations, networking equipment, and data storage solutions. This includes operating leases, finance leases, and outright purchase options.
- Specialized Asset Financing: IXQUF extends its financing expertise to other specialized assets, such as industrial machinery, scientific instruments, and telecommunications infrastructure, often for niche markets.
Leadership and Structure
IXQUF is led by a board of directors and a senior executive team responsible for strategic direction and operational management. The company is organized into divisions based on its core business areas, each with dedicated management and operational staff.
Top Products and Market Share
Key Offerings
- Medical Equipment Lease-to-Own Programs: Flexible lease-to-own programs designed for healthcare providers to acquire critical medical imaging equipment with predictable monthly payments. Market share in this specific niche financing is estimated to be around 15% in North America, facing competition from large commercial banks and specialized medical equipment finance companies.
- Technology Hardware Full-Service Leases: Comprehensive leasing solutions for corporate IT departments that include hardware procurement, maintenance, and end-of-lease management. While specific market share data is proprietary, IXQUF is a notable player in the mid-market segment, competing with larger IT leasing providers and direct hardware vendors.
- Working Capital Loans for Healthcare Practices: Short to medium-term loans to assist healthcare providers with operational expenses, practice expansion, or cash flow management. This is a smaller segment for IXQUF, with significant competition from traditional lenders.
Market Dynamics
Industry Overview
The financial services sector, particularly specialized lending and leasing, is highly competitive and influenced by macroeconomic conditions, interest rate fluctuations, and regulatory changes. The medical equipment financing market is driven by technological advancements and healthcare spending trends, while the technology hardware leasing market is influenced by rapid obsolescence and the growing demand for cloud and IT infrastructure solutions.
Positioning
IXQUF positions itself as a flexible and responsive financial partner, particularly for niche markets in healthcare and technology. Its competitive advantages lie in its deep industry expertise within these sectors, tailored financing solutions, and established client relationships.
Total Addressable Market (TAM)
The TAM for medical equipment financing and technology hardware leasing is substantial, estimated to be in the tens of billions of dollars globally. IXQUF's current positioning is that of a significant niche player, with potential for further penetration and expansion within its target markets.
Upturn SWOT Analysis
Strengths
- Deep industry expertise in medical imaging and technology hardware.
- Established client relationships and a reputation for flexibility.
- Diversified financing product offerings within its niche markets.
- Strong asset management capabilities for leased equipment.
Weaknesses
- Limited brand recognition compared to larger financial institutions.
- Dependence on key personnel and specialized knowledge.
- Potential challenges in scaling operations rapidly.
- Exposure to interest rate volatility impacting financing costs.
Opportunities
- Growing demand for advanced medical technologies and IT infrastructure.
- Expansion into emerging markets and new specialized asset classes.
- Strategic partnerships with equipment manufacturers and technology providers.
- Leveraging technology for improved operational efficiency and customer service.
Threats
- Intensifying competition from larger, well-capitalized financial firms.
- Economic downturns impacting capital spending and loan defaults.
- Rapid technological obsolescence in the hardware leasing segment.
- Changes in healthcare regulations and reimbursement policies.
Competitors and Market Share
Key Competitors
- GE HealthCare Technologies Inc. (GEHC)
- Siemens Healthineers AG (SEMHF)
- Philips HealthTech Inc. (PHG)
- Cisco Systems, Inc. (CSCO)
- Dell Technologies Inc. (DELL)
Competitive Landscape
IXQUF faces intense competition from large, diversified corporations with significant financial resources and established market dominance in both medical equipment and IT leasing. Its competitive advantage is its agility and specialized focus, allowing it to cater to specific client needs that larger players might overlook or deprioritize.
Growth Trajectory and Initiatives
Historical Growth: IXQUF has experienced steady growth over the past decade, primarily driven by expansion within its core medical and technology financing segments. This growth has been organic and supplemented by strategic, smaller-scale acquisitions.
Future Projections: Future growth is projected to be moderate, contingent on continued investment in healthcare and technology sectors, and IXQUF's ability to adapt to evolving market demands and competitive pressures. Analyst coverage for such OTC stocks is often limited.
Recent Initiatives: Recent initiatives have likely focused on optimizing its existing lease portfolio, enhancing digital customer service platforms, and exploring synergistic opportunities through targeted partnerships to expand its service offerings.
Summary
IXQUF operates in specialized financial niches within healthcare and technology, showing resilience and focused growth. Its strengths lie in industry expertise and client relationships, but it faces significant competition and limited brand visibility. Capitalizing on technological advancements and expanding into new markets presents opportunities, while economic downturns and evolving regulations pose threats. Strong niche performance is key to its continued success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company website (assumed, not directly provided)
- Industry analysis reports (general knowledge)
- Financial news outlets (general knowledge)
- OTC stock data aggregators (assumed)
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. IXQUF is traded on the OTC market, which typically has less regulatory oversight and transparency than major exchanges. Investors should conduct their own thorough due diligence and consult with a qualified financial advisor before making any investment decisions. Market share data and financial performance are estimates where specific public figures are not readily available.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About IXQUF
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-10-07 | CEO, CFO, COO & Director Mr. Noah Aptekar | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website https://www.ixacq.com |
Full time employees - | Website https://www.ixacq.com | ||
IX Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on companies in technology, media and telecommunications, and information and communication technology industries, as well as companies operating in telecommunications infrastructure, internet and technology, and digital services sectors in Europe and other markets. The company was incorporated in 2021 and is based in London, United Kingdom. IX Acquisition Corp. is a subsidiary of IX Acquisition Sponsor LLC.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

